{
    "ucits": true,
    "type": "ETF",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "replication_method": "synthetic",
    "complex_factors": "Leverage, Synthetic replication, Derivatives, Structured product features",
    "classification": "complex",
    "supporting_data": "The asset is a UCITS ETF but it is a leveraged 3x product, explicitly providing three times the daily performance of the underlying JD.com ADR, which involves daily rebalancing and compounding effects that increase complexity and risk. The product uses derivatives integral to its strategy, including swaps and margin accounts holding collateral assets, which introduce counterparty and collateral risks. The replication method is synthetic, relying on derivatives rather than physical holding of underlying securities. The product is non-interest bearing, not capital protected, and has a very high risk rating (7/7). The recommended holding period is only one day due to the compounding and leverage effects, which retail investors with basic knowledge are unlikely to fully understand. The product documentation includes a mandatory comprehension alert stating it is not simple and may be difficult to understand. According to MiFID II Article 254, Delegated Regulation EU 2017/565 Article 57, and ESMA guidelines, such featuresu2014leverage beyond UCITS limits, synthetic replication, embedded derivatives, and complex payoff structuresu2014classify the product as complex. UCITS ETFs are generally presumed non-complex, but this presumption is overturned here due to the use of leverage, synthetic replication, and derivatives integral to the investment objective. Therefore, the product fails the non-complex criteria under Article 57, requiring an appropriateness assessment for retail investors."
}